Astrana Health, Inc. (NASDAQ:ASTH – Get Free Report)’s stock price reached a new 52-week low on Monday . The stock traded as low as $31.20 and last traded at $31.35, with a volume of 194714 shares trading hands. The stock had previously closed at $32.18.
Analysts Set New Price Targets
A number of analysts recently issued reports on the company. TD Cowen started coverage on Astrana Health in a research note on Monday, October 14th. They set a “buy” rating and a $66.00 target price for the company. Macquarie upgraded shares of Astrana Health to a “hold” rating in a report on Monday, December 16th. KeyCorp began coverage on shares of Astrana Health in a research note on Friday, October 11th. They issued a “sector weight” rating for the company. Robert W. Baird lifted their price target on Astrana Health from $67.00 to $86.00 and gave the company an “outperform” rating in a research note on Wednesday, November 13th. Finally, BTIG Research upped their price objective on Astrana Health from $60.00 to $70.00 and gave the stock a “buy” rating in a research report on Thursday, October 3rd. Two research analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $65.17.
Get Our Latest Stock Analysis on Astrana Health
Astrana Health Stock Performance
Astrana Health (NASDAQ:ASTH – Get Free Report) last announced its quarterly earnings results on Thursday, November 7th. The company reported $0.33 EPS for the quarter, meeting analysts’ consensus estimates of $0.33. The firm had revenue of $478.71 million during the quarter, compared to analysts’ expectations of $462.01 million. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. During the same quarter last year, the company posted $0.47 earnings per share. On average, equities analysts forecast that Astrana Health, Inc. will post 1.16 EPS for the current fiscal year.
Institutional Trading of Astrana Health
Hedge funds have recently made changes to their positions in the business. State Street Corp bought a new position in Astrana Health in the 3rd quarter valued at about $91,966,000. Geode Capital Management LLC bought a new position in shares of Astrana Health in the 3rd quarter valued at $58,995,000. FMR LLC acquired a new position in Astrana Health during the third quarter worth about $48,413,000. SteelPeak Wealth LLC bought a new position in Astrana Health in the 3rd quarter valued at approximately $39,398,000. Finally, Loomis Sayles & Co. L P acquired a new stake in shares of Astrana Health during the 3rd quarter valued at $30,251,000. 52.77% of the stock is owned by institutional investors and hedge funds.
About Astrana Health
Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.
Further Reading
- Five stocks we like better than Astrana Health
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Build-Your-Bowl Battle: CAVA, Chipotle, and Sweetgreen Face Off
- The Most Important Warren Buffett Stock for Investors: His Own
- Insiders Are Loading Up: 3 Key Stock Picks for Investors
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- How Cigna Remains at the Top of the Health Insurance Food Chain
Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.